Deep Track Capital, LP

Company	Share, %
Orchard Therapeutics plc	89.7
Relmada Therapeutics, Inc.	20.66
Bicycle Therapeutics plc	16.38
Nektar Therapeutics	10.02
Pliant Therapeutics, Inc.	9.55
Terns Pharmaceuticals, Inc.	9.44
Jounce Therapeutics, Inc.	8.09
Aligos Therapeutics, Inc.	8.07
AnaptysBio, Inc.	7.61
Pyxis Oncology, Inc.	7.11
Dynavax Technologies Corporation	6.98
Editas Medicine, Inc.	6.69
Editas Medicine	6.69
Silence Therapeutics plc	6.52
Repare Therapeutics Inc.	6.32
Verona Pharma plc	6.15
Ambrx Biopharma Inc.	5.88
4D Molecular Therapeutics, Inc.	5.87
HilleVax, Inc.	5.83
Zura Bio Limited	5.79